Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06003998
Title Intraperitoneal Irinotecan With Concomitant FOLFOX and Bevacizumab (INTERACT-II)
Acronym INTERACT-II
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Catharina Ziekenhuis Eindhoven
Indications
Therapies
Age Groups: adult | senior
Covered Countries NLD


No variant requirements are available.